Analysis of the effects of Gadd34 inhibition to impaired liver regeneration in NAFLD
Project/Area Number |
25861179
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Multi-year Fund |
Research Field |
Digestive surgery
|
Research Institution | Kanazawa University |
Principal Investigator |
INABA YUKA 金沢大学, 脳・肝インターフェースメディシン研究センター, 特任助教 (20571970)
|
Project Period (FY) |
2013-04-01 – 2015-03-31
|
Project Status |
Completed (Fiscal Year 2014)
|
Budget Amount *help |
¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2014: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Fiscal Year 2013: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
|
Keywords | NAFLD / 肝切除 / 肝再生 / 統合的ストレス応答 / Gadd34 / eIF2a / アデノ随伴ウィルス / eIF2α / 小胞体ストレス |
Outline of Final Research Achievements |
The liver has robust regenerative potential in response to damage, but hepatic steatosis weakens this potential. We found that the enhanced integrated stress response (ISR) mediated by phosphorylation of eIF2α impairs regeneration in hepatic steatosis. Gadd34 is known to regulate ISR by dephosphorylation of eIF2α. Gadd34 knockdown enhanced ISR, reduced hepatocyte proliferation, increased cell death, and increased plasma ALT levels. In contrast, Gadd34 overexpression suppressed ISR, hepatocyte apoptosis without affecting hepatocyte proliferation, and decreased plasma ALT levels, clearly improving fatty liver regeneration. These data suggest that Gadd34-mediated regulation of ISR acts as a physiological defense mechanism against impaired liver regeneration due to steatosis.
|
Report
(3 results)
Research Products
(7 results)
-
[Journal Article] Gadd34 regulates liver regeneration in hepatic steatosis.2015
Author(s)
Inaba Y, Furutani T, Kimura K, Watanabe H, Haga S, Kido Y, Yamamoto Y, Harada K, Kaneko S, Oyadomari S, Ozaki M, Kasuga M, Inoue H.
-
Journal Title
Hepatology
Volume: 61(4)
Issue: 4
Pages: 1343-1356
DOI
Related Report
Peer Reviewed / Open Access
-
[Journal Article] Histidine augments the suppression of hepatic glucose production by central insulin action.2013
Author(s)
Kimura K, Nakamura Y, Inaba Y, Matsumoto M, Kido Y, Asahara S, Matsuda T, Watanabe H, Maeda A, Inagaki F, Mukai C, Takeda K, Akira S, Ota T, Nakabayashi H, Kaneko S, Kasuga M, Inoue H.
-
Journal Title
Diabetes
Volume: 62
Issue: 7
Pages: 2266-77
DOI
Related Report
Peer Reviewed
-
-
-
-
-